US Stock MarketDetailed Quotes

TTNP Titan Pharmaceuticals

Watchlist

6.7183
+0.0425+0.64%

Close May 23 16:00 ET

6.14MMarket Cap-1046P/E (TTM)

Titan Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

67.72%-613K

13.33%-7.09M

-42.24%-2.25M

2.03%-1.84M

37.07%-1.11M

35.93%-1.9M

-3.60%-8.18M

-46.07%-1.58M

17.20%-1.87M

8.49%-1.77M

Net income from continuing operations

36.72%-1.06M

45.43%-5.57M

23.23%-1.97M

87.19%-338K

35.58%-1.59M

34.06%-1.68M

-16.29%-10.21M

-1.02%-2.57M

-37.75%-2.64M

-46.55%-2.46M

Operating gains losses

----

---1.76M

---23K

----

Depreciation and amortization

-95.35%2K

-42.86%112K

-93.33%3K

-43.75%27K

-23.53%39K

-17.31%43K

-11.31%196K

-15.09%45K

-14.29%48K

-10.53%51K

Other non cash items

---1K

-94.91%23K

-94.67%24K

----

1,358.06%452K

1,116.22%450K

--0

125.00%1K

Change In working capital

180.07%446K

-342.33%-916K

-156.26%-328K

-214.77%-202K

-57.14%171K

28.59%-557K

272.60%378K

-52.33%583K

116.46%176K

543.33%399K

-Change in receivables

4,972.22%913K

-113.16%-10K

-176.92%-10K

-134.62%-18K

--0

116.98%18K

-90.16%76K

-95.85%13K

116.15%52K

-60.20%117K

-Change in inventory

----

--0

----

434.29%187K

315.85%354K

--9K

----

-Change in prepaid assets

-20.20%-119K

7.93%177K

-72.22%55K

43.75%46K

-18.60%175K

64.77%-99K

0.61%164K

-40.54%198K

120.65%32K

-4.87%215K

-Change in payables and accrued expense

11.11%-336K

-1,898.00%-899K

-549.40%-373K

-1,638.46%-226K

-73.01%78K

-22.33%-378K

103.37%50K

-81.39%83K

97.80%-13K

141.34%289K

-Change in other working capital

87.76%-12K

-85.86%-184K

--0

-104.17%-4K

-78.26%-82K

-16.67%-98K

-133.56%-99K

---65K

--96K

---46K

Cash from discontinued investing activities

Operating cash flow

67.72%-613K

13.33%-7.09M

-42.24%-2.25M

2.03%-1.84M

37.07%-1.11M

35.93%-1.9M

-3.60%-8.18M

-46.07%-1.58M

17.20%-1.87M

8.49%-1.77M

Investing cash flow

Cash flow from continuing investing activities

732K

504K

Net PPE purchase and sale

----

---2K

----

--0

----

Net other investing changes

----

--734K

--506K

----

Cash from discontinued investing activities

Investing cash flow

----

--732K

--504K

----

--0

----

Financing cash flow

Cash flow from continuing financing activities

100.64%10M

406K

9.59M

-43.63%4.98M

Net issuance payments of debt

----

--500K

--0

----

--0

----

Net common stock issuance

----

--0

----

-43.67%4.98M

--0

Net preferred stock issuance

----

--9.5M

--406K

----

--0

----

Proceeds from stock option exercised by employees

----

--0

----

--4K

--0

--3K

Cash from discontinued financing activities

Financing cash flow

----

100.64%10M

--406K

--9.59M

----

-43.63%4.98M

--0

--3K

Net cash flow

Beginning cash position

116.15%6.77M

-50.52%3.13M

72.09%8.11M

-98.15%122K

-85.22%1.23M

-50.52%3.13M

16.98%6.33M

-36.48%4.71M

-31.97%6.59M

-28.21%8.35M

Current changes in cash

67.72%-613K

213.79%3.64M

15.39%-1.34M

526.43%7.99M

36.96%-1.11M

-194.15%-1.9M

-448.10%-3.2M

-45.40%-1.58M

17.20%-1.87M

9.49%-1.76M

End cash Position

399.11%6.16M

116.18%6.77M

72.09%8.11M

-98.15%122K

-85.22%1.23M

-50.52%3.13M

-36.48%4.71M

-31.97%6.59M

Free cash flow

67.72%-613K

13.31%-7.09M

-42.37%-2.25M

2.03%-1.84M

37.07%-1.11M

35.93%-1.9M

-3.29%-8.18M

-45.40%-1.58M

17.20%-1.87M

9.34%-1.77M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	67.72%-613K	13.33%-7.09M	-42.24%-2.25M	2.03%-1.84M	37.07%-1.11M	35.93%-1.9M	-3.60%-8.18M	-46.07%-1.58M	17.20%-1.87M	8.49%-1.77M
Net income from continuing operations	36.72%-1.06M	45.43%-5.57M	23.23%-1.97M	87.19%-338K	35.58%-1.59M	34.06%-1.68M	-16.29%-10.21M	-1.02%-2.57M	-37.75%-2.64M	-46.55%-2.46M
Operating gains losses	----	---1.76M	---23K	----	----	----	----	----	----	----
Depreciation and amortization	-95.35%2K	-42.86%112K	-93.33%3K	-43.75%27K	-23.53%39K	-17.31%43K	-11.31%196K	-15.09%45K	-14.29%48K	-10.53%51K
Other non cash items	---1K	-94.91%23K	-94.67%24K	----	----	----	1,358.06%452K	1,116.22%450K	--0	125.00%1K
Change In working capital	180.07%446K	-342.33%-916K	-156.26%-328K	-214.77%-202K	-57.14%171K	28.59%-557K	272.60%378K	-52.33%583K	116.46%176K	543.33%399K
-Change in receivables	4,972.22%913K	-113.16%-10K	-176.92%-10K	-134.62%-18K	--0	116.98%18K	-90.16%76K	-95.85%13K	116.15%52K	-60.20%117K
-Change in inventory	----	--0	--0	--0	----	----	434.29%187K	315.85%354K	--9K	----
-Change in prepaid assets	-20.20%-119K	7.93%177K	-72.22%55K	43.75%46K	-18.60%175K	64.77%-99K	0.61%164K	-40.54%198K	120.65%32K	-4.87%215K
-Change in payables and accrued expense	11.11%-336K	-1,898.00%-899K	-549.40%-373K	-1,638.46%-226K	-73.01%78K	-22.33%-378K	103.37%50K	-81.39%83K	97.80%-13K	141.34%289K
-Change in other working capital	87.76%-12K	-85.86%-184K	--0	-104.17%-4K	-78.26%-82K	-16.67%-98K	-133.56%-99K	---65K	--96K	---46K
Cash from discontinued investing activities
Operating cash flow	67.72%-613K	13.33%-7.09M	-42.24%-2.25M	2.03%-1.84M	37.07%-1.11M	35.93%-1.9M	-3.60%-8.18M	-46.07%-1.58M	17.20%-1.87M	8.49%-1.77M
Investing cash flow
Cash flow from continuing investing activities		732K	504K				0	0
Net PPE purchase and sale	----	---2K	----	----	----	----	--0	----	----	----
Net other investing changes	----	--734K	--506K	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	----	--732K	--504K	----	----	----	--0	--0	----	----
Financing cash flow
Cash flow from continuing financing activities		100.64%10M	406K	9.59M			-43.63%4.98M	0	0	3K
Net issuance payments of debt	----	--500K	--0	----	----	----	--0	--0	----	----
Net common stock issuance	----	--0	--0	--0	----	----	-43.67%4.98M	--0	--0	--0
Net preferred stock issuance	----	--9.5M	--406K	----	----	----	--0	--0	----	----
Proceeds from stock option exercised by employees	----	--0	--0	--0	----	----	--4K	--0	--0	--3K
Cash from discontinued financing activities
Financing cash flow	----	100.64%10M	--406K	--9.59M	----	----	-43.63%4.98M	--0	--0	--3K
Net cash flow
Beginning cash position	116.15%6.77M	-50.52%3.13M	72.09%8.11M	-98.15%122K	-85.22%1.23M	-50.52%3.13M	16.98%6.33M	-36.48%4.71M	-31.97%6.59M	-28.21%8.35M
Current changes in cash	67.72%-613K	213.79%3.64M	15.39%-1.34M	526.43%7.99M	36.96%-1.11M	-194.15%-1.9M	-448.10%-3.2M	-45.40%-1.58M	17.20%-1.87M	9.49%-1.76M
End cash Position	399.11%6.16M	116.18%6.77M	116.18%6.77M	72.09%8.11M	-98.15%122K	-85.22%1.23M	-50.52%3.13M	-50.52%3.13M	-36.48%4.71M	-31.97%6.59M
Free cash flow	67.72%-613K	13.31%-7.09M	-42.37%-2.25M	2.03%-1.84M	37.07%-1.11M	35.93%-1.9M	-3.29%-8.18M	-45.40%-1.58M	17.20%-1.87M	9.34%-1.77M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall